LISATA THERAPEUTICS INC. - COMMON STOCK

2.7140

04-February-25 16:45:00

15 minutes delayed

Stocks

+0.1340

+5.19%

Today's range

2.5300 - 2.7332

ISIN

N/A

Source

NASDAQ

Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2022

07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
Lisata Therapeutics to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022, at 4:30 p.m. Eastern Time

03 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
Lisata Therapeutics Announces Participation in Upcoming Conferences in October 2022

06 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award

29 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.